Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Apic Bio
700 Main Street, North
Cambridge, MA 02139
Phone: 857-302-3757
https://www.apic-bio.com/

Apic Bio is committed to finding cures for patients with genetic diseases. The company is a spin-off from the University of Massachusetts Medical School (UMMS) and is based upon nearly 30 years of gene therapy research by Apic's scientific founders. Apic is developing best-in-class treatment options for rare, devastating neurological and liver diseases. Its current pipeline focuses on new and effective treatments for Alpha-1 Antitrypsin Deficiency (Alpha-1, or AATD) and genetic Amyotrophic Lateral Sclerosis (ALS.)

Key Contact
NameTitleE-Mail
John ReillyCEO


Funding Events
DateAmountTypeInvestors
01/08/19$40,000,000Series A A1ATD Investors
Alpha-1 Project
ALS Investment Fund
Morningside Venture  
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.